MAAT INDEX

CLAIM #67766 · Zscaler Inc (ZS) · 2022Q3 earnings call · Sep 8, 2022 · due Jul 31, 2022

we expect duration to fall within the normal 10 to 14 months range.

Remo Canessa · CFO

PENDING
graded after results covering Jul 31, 2022 are reported

In context

Remo Canessa (CFO): Yes. That's a great question. When examining our RPO and CRPO growth on a year-over-year basis, those are committed deals. Our RPO growth was 83% and our CRPO growth was 75%. Concerning duration, it was comparable on a year-over-year basis. There are no headwinds here; we expect duration to fall within the normal 10 to 14 months range. Thus, the key insight from billings is that it reflects calculated billings, which is derived from deferred revenue. We consistently monitor RPO and CRPO growth rates, with RPO at 83% and CRPO at 75% year-over-year. However, while these metrics are impressive, we believe billings remain the best measure for Zscaler, given the typical duration of 10 to 14 months. The actual commitments made by customers to Zscaler are quite noteworthy.

Verify independently

SEC filings for ZS · Claim quote is verbatim from the 2022Q3 earnings call.